A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology - Canada
doi 10.3747/co.v18i3.732
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Efficacy and Safety of Cannabidiol Followed by an Open Label Add-On of Tetrahydrocannabinol for the Treatment of Chronic Pain in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis: Protocol for a Multicentre, Randomised, Placebo-Controlled Study

BMJ Open
Medicine
2019English

The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study

HIV Clinical Trials
2015English

Efficacy and Safety of Oxycodone Injection for Relieving Cancer Pain: A Study in Japan Consisting of Two Open Trials for Intravenous and Subcutaneous Administration

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2018English

Efficacy of a Standardized Herbal Preparation (Roidosanal®) in the Treatment of Hemorrhoids: A Randomized, Controlled, Open-Label Multicentre Study

Journal of Ayurveda and Integrative Medicine
Drug DiscoveryAlternative MedicineComplementary
2014English

Clinical Efficacy and Safety of “Vasavaleha” in the Management of Stable Chronic Bronchitis: A Prospective Open Label Multicenter Study

Journal of Research in Ayurvedic Sciences
2017English

Study Protocol for an Open-Label, Single-Arm, Multicentre Phase II Trial to Evaluate the Efficacy and Safety of Combined Triplet Therapy and Olanzapine for Prevention of Carboplatin-Induced Nausea and Vomiting in Gynaecological Cancer Patients

BMJ Open
Medicine
2019English

Efficacy and Safety of Two Ayurvedic Dosage Forms for Allergic Rhinitis: Study Protocol for an Open-Label Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2017English

Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study

BMJ Open
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy